enGene Holdings Inc. (ENGN)

enGene Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Net Income	-122.34	-99.92	-24.46	-23.44	-15.07
Depreciation & Amortization	0.29	0.18	0.24	0.27	0.26
Other Amortization	-	0.92	-	-	-
Stock-Based Compensation	7.02	3.45	0.12	0.44	0.15
Other Operating Activities	70.79	71.14	4.34	7.79	1.21
Change in Accounts Payable	1.32	0.37	-0.2	0.11	0.22
Change in Other Net Operating Assets	5.12	0.12	2.23	-1.44	0.31
Operating Cash Flow	-35.49	-24.74	-17.59	-15.98	-13.06
Capital Expenditures	-0.83	-0.32	-0.15	-0.25	-0.19
Sale of Property, Plant & Equipment	-	-	-	0	-
Investing Cash Flow	-0.83	-0.32	-0.15	-0.25	-0.19
Long-Term Debt Issued	-	38	29.4	8.03	13.01
Long-Term Debt Repaid	-	-4.73	-1.01	-0.96	-
Net Debt Issued (Repaid)	8.71	33.27	28.39	7.07	13.01
Issuance of Common Stock	263	56.94	0.01	0.01	-
Other Financing Activities	-15.32	-4.06	-0.44	-0.14	-0.16
Financing Cash Flow	256.4	86.15	27.97	22.53	12.85
Foreign Exchange Rate Adjustments	0	0	-0.81	0.1	-0.05
Net Cash Flow	220.08	61.09	9.42	6.39	-0.46
Free Cash Flow	-36.31	-25.06	-17.75	-16.23	-13.25
Free Cash Flow Per Share	-1.35	-36.18	-27.09	-4.56	-4.80
Cash Interest Paid	1.85	1.4	0.62	-	-
Levered Free Cash Flow	-23.58	-16.07	-10.75	-	-
Unlevered Free Cash Flow	-21.58	-13.89	-9.86	-	-
Change in Net Working Capital	-6.49	0.91	-2.08	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.